Search Results

0 results for 'Allergan'

You can use to get even better search results Allergan
December 11, 2024 | Law.com

What Does Ohio Supreme Court's Opioid Decision Mean for Public Nuisance Claims?

The Ohio Supreme Court's decision on Tuesday could impact other opioid litigation and possibly influence other mass torts, such as those over social media or mass shootings.
6 minute read
November 19, 2024 | The Legal Intelligencer

A Deep Dive Into the Product-Line Exception in Pennsylvania

Imagine as a product manufacturer being held liable for defects in a product that you did not make, have never made, and have no plans to make. This very real possibility exists in Pennsylvania under what is commonly referred to as “the product-liability exception” to the general rule of successor nonliability. Although it has been around for close to 50 years, the exception is not well-developed in Pennsylvania.
8 minute read
November 15, 2024 | National Law Journal

Baltimore City Govt., After Winning Opioid Jury Trial, Preparing to Demand an Additional $11B for Abatement Costs

Susman Godfrey partner Bill Carmody said the $266 million “verdict was an important step toward helping Baltimore recover so that it can continue to be one of the best cities in America and a place where all of its citizens can be healthy and succeed."
3 minute read
September 16, 2024 | Law.com

Federal Circuit Decision Clarifies Obviousness-Type Double Patenting and Patent Term Adjustments In 'Allergan v. MSN Laboratories'

On August 13, the Federal Circuit issued a precedential ruling that reversed the District of Delaware's application of the Federal Circuit precedent in In re: Cellect to invalidate a claim in an earlier-filed parent application over admittedly patentably indistinct claims in later-filed (and earlier-expired) child patents. This decision has resolved some substantial questions about the application of obviousness-type double patenting that had been raised by last year's In re Cellect decision.
7 minute read
August 16, 2024 | Litigation Daily

Litigator of the Week Runners-Up and Shout-Outs

A team at Covington & Burling knocked out a $107.5 million patent infringement verdict facing pharmaceutical client AstraZeneca.
5 minute read
July 02, 2024 | Law.com

Litigation Surge: Big Pharma Sues 5 States Over Drug Discounts

Further, the court said, "states have begun to impose explicitly what [The Department of Health and Human Services] had purported to impose by guidance."
3 minute read
July 02, 2024 | Connecticut Law Tribune

Big Pharma Sues 5 States Over Drug Discounts

Further, the court said, "states have begun to impose explicitly what [The Department of Health and Human Services] had purported to impose by guidance."
3 minute read
June 14, 2024 | Litigation Daily

Litigators of the Week Runners-Up

Kirkland & Ellis scored a knockout win for Sun Pharmaceutical Industries Ltd. in a more than decadelong multidistrict litigation where the company was accused of conspiring to delay the launch of a generic version of the blockbuster cholesterol drug Lipitor.
7 minute read
May 14, 2024 | National Law Journal

2nd Circuit Clarifies When 'Pay-for-Delay' Deals Are Legal in Tossing Antitrust Claims

The appeals court said the settlement payments in the underlying case represented fair value for goods or services in a commercial relationship, thus justified under the Supreme Court's decision in "Federal Trade Commission v. Actavis."
3 minute read

Resources

  • Why Embracing Change Is Essential for Your Legal Department

    Brought to you by DiliTrust

    Download Now

  • International Export and Trade Assistance State Law Survey

    Brought to you by LexisNexis®

    Download Now

  • How This Personal Injury Firm Reduced Client Intake Time by 80%

    Brought to you by PracticePanther

    Download Now

  • The Hidden Cost of Bad Reviews: Why Law Firms & Attorneys Can't Afford a Damaged Online Reputation

    Brought to you by Erase.com

    Download Now